EP-0226
N/A
Report date: 2026/02/11 20:01:36
NME
Base Information
Drug NameEP-0226
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Easton Biopharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesZhongshan Institute for Drug DiscoveryChengdu Easton Biopharmaceuticals Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A